MYoroface AB is a research driven MedTech company that has developed and patented the neuromuscular training device IQoro. With only 90 seconds’ training per day, IQoro treats the underlying causes of conditions like reflux, dysphagia, snoring and leaping apnea. The device is the product of 20 years’ scientific clinical research. The company was founded in 2012 and has customers throughout Europe. IQoro is a CE marked, Class 1 medical device, recommended by NICE (National Institute for Health and Care Excellence) and available to prescribe on the NHS. For more information visit our website www.iqoro.com.

Privacy Policy